Mark E. Davis, a successful chemical engineer, never dreamed that he would reinvent his career and create a revolutionary kind of cancer drug. But everything changed when his wife was diagnosed with breast cancer. 10 years later, IT-101, the nanoparticle drug he engineered, was approved for a six-month trial in humans. Also, meet a group of young, hopeful scientists who are setting their sights on a resource that provides enough energy in one hour to power the entire globe for one year-the sun. They believe they can create an “artificial leaf” that uses sunlight to split water into hydrogen and oxygen.
Please note that the THIRTEEN editorial staff reserves the right to not post comments it deems to be inappropriate and/or malicious in nature, as well as edit comments for length, clarity and fairness. No solicitations or advertisements will be allowed. Users may link to other Web sites relevant to discussion, but most often links to commercial Web sites will not be permitted.
